EUVIMEDEUVIMED entdecken
Video/Audio

Integrated Network Pharmacology, Metabolomics, And in vivo Validation of Liangxue Dihuang Decoction In DSS-Induced Ulcerative Colitis Mice

Jie Pan, Yue Wang, Jinchen Chong

Journal of Visualized Experiments · 2026

DOI: 10.3791/70805 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Jie Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Metabolomics, Drugs, Chinese Herbal, Network Pharmacology. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by persistent intestinal inflammation and metabolic dysregulation. Traditional Chinese medicine (TCM) formulas are widely used in clinical practice for inflammatory disorders; however, systematic experimental approaches to elucidate their multi-component and multi-target mechanisms remain limited. This article presents a reproducible experimental protocol integrating network pharmacology, untargeted metabolomics, and in vivo validation to investigate the anti-inflammatory effects of Liangxue Dihuang Decoction (LXDHD) in a dextran sulfate sodium (DSS)-induced mouse model of UC. The workflow includes preparation of the herbal decoction, DSS-induced colitis modeling, disease activity assessment, histopathological and hematological evaluation, serum cytokine measurement, LC-MS-based metabolomic profiling, and computational network analysis. Using this integrated approach, DSS-induced colitis was successfully established, and LXDHD treatment resulted in measurable improvements in the disease activity index, colon length, histopathological damage, inflammatory cytokine levels, and metabolic profiles. Network pharmacology and metabolomics analyses further demonstrated that this protocol enables the identification of key targets, pathways, and metabolites associated with therapeutic intervention. This visualized and standardized workflow provides a practical methodological framework for studying the pharmacological mechanisms of multi-component TCM formulas in inflammatory bowel disease and can be adapted to other herbal prescriptions and disease models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeMetabolomicsDrugs, Chinese HerbalNetwork PharmacologyAnti-Inflammatory AgentsAnimalsDextran SulfateMiceDisease Models, AnimalMaleMice, Inbred C57BL

Substanzen

Dextran SulfateDrugs, Chinese HerbalAnti-Inflammatory Agents

Autor:innen und Institutionen

  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine.
  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine; wangyue@njucm.edu.cn.
  • The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine; cjc00075@163.com.

Zitieren

APA

Pan, J., Wang, Y., & Chong, J. (2026). Integrated Network Pharmacology, Metabolomics, And in vivo Validation of Liangxue Dihuang Decoction In DSS-Induced Ulcerative Colitis Mice. Journal of Visualized Experiments. https://doi.org/10.3791/70805

Vancouver

Pan J, Wang Y, Chong J. Integrated Network Pharmacology, Metabolomics, And in vivo Validation of Liangxue Dihuang Decoction In DSS-Induced Ulcerative Colitis Mice. Journal of Visualized Experiments. 2026. doi:10.3791/70805

BibTeX
@article{Pan2026,
  author = {Pan, Jie and Wang, Yue and Chong, Jinchen},
  title = {Integrated Network Pharmacology, Metabolomics, And in vivo Validation of Liangxue Dihuang Decoction In DSS-Induced Ulcerative Colitis Mice},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70805}
}
Kostenlos starten →